References

Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial

10.1093/eurheartj/ehae043 · 2024 · External reference

Transcatheter vs surgical aortic valve replacement in lower-risk patients: an updated meta-analysis of randomized controlled trials

10.1016/j.jacc.2024.12.031 · 2025 · External reference

ESC/EACTS Scientific DocumentGroup. 2025 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2025;46:4635-4736. https://doi.org/10.1093/eurheartj/ehaf194

External reference

Transcatheter aortic valve implantation in low-risk tricuspid or bicuspid aortic stenosis: the NOTION-2 trial

10.1093/eurheartj/ehae331 · 2024 · External reference

Deformation of transcatheter aortic valve prostheses: implications for hypoattenuating leaflet thickening and clinical outcomes

10.1161/circulationaha.121.058339 · 2022 · External reference

Post-implant transcatheter aortic prosthesis deformation: tricuspid versus bicuspid valve

10.1093/ejcts/ezae451 · 2024 · External reference

Predictors of outcomes of reintervention after transcatheter aortic valve replacement: FRANCE 2 and FRANCE TAVI registries

10.1016/j.jacc.2024.11.048 · 2025 · External reference

Transcatheter aortic valve replacement in patients with severe aortic stenosis and heart failure

10.1007/s10741-018-9726-8 · 2018 · External reference

Systematic CT methodology for the evaluation of subclinical leaflet thrombosis

10.1016/j.jcmg.2017.02.005 · 2017 · External reference

Colchicine in patients with aortic stenosis undergoing transcatheter aortic valve replacement: a double-blind randomized trial

10.1038/s41467-025-61916-6 · 2025 · External reference

Bioprosthetic aortic valve leaflet thickening in the evolut low risk sub-study

10.1016/j.jacc.2020.03.022 · 2020 · External reference

Valvular and perivalvular thrombosis following self-expandable aortic valve replacement: analysis of 100 multi-detector computed tomography scans

10.1093/ehjopen/oeae085 · 2024 · External reference

Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy

10.1016/j.jacc.2020.04.043 · 2020 · External reference

Visualizing the effects of predictor variables in black box supervised learning models

10.1111/rssb.12377 · 2020 · External reference

Unresolved reference

External reference

Greedy function approximation: a gradient boosting machine

10.1214/aos/1013203451 · 2001 · External reference

Assisted artificial intelligence in medical writing: a primer for humans

10.1093/ejcts/ezaf167 · 2025 · External reference

10.1145/2939672.2939785

10.1145/2939672.2939785 · External reference

Predicting subclinical leaflet thrombosis in self-expandable prosthesis: a multimodal machine learning analysis

10.1016/j.xjse.2025.100064 · 2025 · External reference

Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration

10.1097/ede.0b013e3181577511 · 2007 · External reference

Thrombocytopaenia after implantation of the Perceval S aortic bioprosthesis

10.1016/j.jtcvs.2019.07.046 · 2020 · External reference

Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can risk stratify patients in transcatheter aortic-valve replacement (TAVR)

10.1016/j.ijcard.2016.08.260 · 2016 · External reference

Three-dimensional analysis of subclinical leaflet thrombosis following transcatheter aortic valve replacement

10.1093/ehjci/jeae051 · 2024 · External reference

Bicuspid aortic valve disease: classifications, treatments, and emerging transcatheter paradigms

10.1016/j.shj.2023.100227 · 2024 · External reference

Acquired thrombocytopaenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes

10.1093/eurheartj/ehu082 · 2014 · External reference

Subclinical leaflet thrombosis and subclinical aortic valve complex thrombosis in TAVR

10.1016/j.jacadv.2025.102085 · 2025 · External reference